Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Cooper

Showing results (41-50 of 363) with videos related to

Pageof 37
Sort By:
AIDS (London, England)|May 1, 1991
Neurological manifestations of HIV-1 infectionB J Brew, D A Cooper
AIDS (London, England)|February 1, 1995
The European-Australian Collaborative Group Study 017 of zidovudine versus placeboJ W Mulder, D A Cooper
Current Opinion in Infectious Diseases|April 20, 2002
The impact of HIV therapy on co-infection with hepatitis B and hepatitis C virusesG J Dore, D A Cooper
The Medical Journal of Australia|July 7, 1986
AIDS and prostitutesD A Cooper, A J Dodds
AIDS (London, England)|August 1, 1990
Factors influencing outcome of treatment with zidovudine of patients with AIDS in Australia. The Australian Zidovudine Study GroupC E Swanson, D A Cooper
The Medical Journal of Australia|October 3, 1988
The surveillance definition of the acquired immunodeficiency syndrome and the clinical classification of infection with the human immunodeficiency virus type 1B M Whyte, D A Cooper
AIDS (London, England)|January 1, 1996
Clinical treatmentD A Cooper, T C Merigan
The Medical Journal of Australia|February 12, 2002
Bridging the divide: global inequities in access to HIV/AIDS therapyG J Dore, D A Cooper
The Medical Journal of Australia|November 20, 1995
If it's the virus, why aren't we measuring it?S Emery, A Carr, D A Cooper
Journal of Clinical Immunology|March 1, 1991
Allergic manifestations of human immunodeficiency virus (HIV) infectionA Carr, D A Cooper, R Penny
Pageof 37

Showing results (41-50 of 363) with videos related to

Sort By:
Pageof 37
AIDS (London, England)|May 1, 1991
Neurological manifestations of HIV-1 infectionB J Brew, D A Cooper
AIDS (London, England)|February 1, 1995
The European-Australian Collaborative Group Study 017 of zidovudine versus placeboJ W Mulder, D A Cooper
Current Opinion in Infectious Diseases|April 20, 2002
The impact of HIV therapy on co-infection with hepatitis B and hepatitis C virusesG J Dore, D A Cooper
The Medical Journal of Australia|July 7, 1986
AIDS and prostitutesD A Cooper, A J Dodds
AIDS (London, England)|August 1, 1990
Factors influencing outcome of treatment with zidovudine of patients with AIDS in Australia. The Australian Zidovudine Study GroupC E Swanson, D A Cooper
The Medical Journal of Australia|October 3, 1988
The surveillance definition of the acquired immunodeficiency syndrome and the clinical classification of infection with the human immunodeficiency virus type 1B M Whyte, D A Cooper
AIDS (London, England)|January 1, 1996
Clinical treatmentD A Cooper, T C Merigan
The Medical Journal of Australia|February 12, 2002
Bridging the divide: global inequities in access to HIV/AIDS therapyG J Dore, D A Cooper
The Medical Journal of Australia|November 20, 1995
If it's the virus, why aren't we measuring it?S Emery, A Carr, D A Cooper
Journal of Clinical Immunology|March 1, 1991
Allergic manifestations of human immunodeficiency virus (HIV) infectionA Carr, D A Cooper, R Penny
Pageof 37